Another Study Finds Heart Inflammation Higher After Moderna Vaccination Versus Pfizer Authored by Zachary Stieber via The Epoch Times (emphasis...
With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’...
SiSaf’s novel Bio-Courier delivery system that combines inorganic silicon and organic lipid vesicles offers a solution for the current shortcomings of...
With cases of drug-resistant tuberculosis on the rise again around the world, GSK has sparked hopes of a The post As resistant tuberculosis rises, GSK...
Farmington, CT– Millions have died due to COVID-19 infection, and millions more continue experiencing the chronic condition, Long COVID, which makes...
A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the...
The most stable storage and most efficient mRNA delivery was achieved by branching lipid CL4F 8-6. This particular lipid could be used in lipid nanoparticles...
Messenger RNA (mRNA) are biological molecules that transfer the information coded by genes in the nucleus to the cytoplasm for protein synthesis by ribosomes....
Significant immunological differences between young men and women were shown to mediate sex differences in the responses to the virus that causes COVID-19,...
Christian Olsen, PhD, business segment lead at Dotmatics, discusses the balancing act needed to succeed at the fulcrum of the incredible potential that...
BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose The post Pfizer/BioNTech begin phase 1 of COVID-19/influenza...
PCR-based diagnostics offer several advantages over conventional diagnostics including speed, sensitivity, specificity, multiplexing capabilities, and...
Australia’s CSL is the latest vaccines company to buy into the mRNA category, tapping US biotech Arcturus Therapeutics The post CSL makes $4bn+ move...
RNA / 8 - 9 February 2023 / London, UK The post 14th Annual RNA Therapeutics Conference appeared first on .
In the historic campaign to vaccinate the world against Covid-19, Corbevax was far from the first vaccine to reach the market. While the first mRNA shot...
In a ceremony on October 21, 2022, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) announced a new partnership...
A recent preprint suggesting SARS-CoV-2 came from a lab has reignited the fierce debate over the origins of the virus.
Gilead Sciences has been knocked back in its quest to bring the first drug therapy for hepatitis D The post FDA rejects Gilead’s hepatitis D therapy...
Many people face persistent cognitive symptoms after COVID-19. A new study, which grew and examined 3D models of the human brain, offers a possible explanation...
Tens of thousands of children have tested positive for respiratory syncytial virus in the last months in what is the largest outbreak of the virus in...
Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is based on mRNA, which has also been put to good use...
During Chardan's recent 6th Annual Genetic Medicines Conference in New York, held in-person for the first time since the COVID-19 pandemic, leaders from...
Less Than 1 In 100 Million Chance That COVID-19 Has Natural Origin: New Study Authored by Hans Mahncke via The Epoch Times (emphasis ours), A...
David Hollander → Revance feels like it has a competitive advantage over AbbVie’s blockbuster Botox with only biannual injections of its freshly approved...
Everest Medicines said its Covid-19 messenger RNA partner passed a mid-stage test investigating its vaccine against Pfizer and BioNTech’s Comirnaty. Providence...
PORTLAND, Ore. – A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new “universal”...
Moderna CEO Confirms New mRNA 'Injection' To Repair Heart Muscles After Heart Attack Authored by Jack Phillips via The Epoch Times (emphasis...
With COVID-19 on the scene, talk of other respiratory viruses has taken a backseat. But this doesn’t change the fact that they are as present as...
The COVID-19 pandemic has turned RNA into a household word, but what new innovations and changes will we see in the RNA therapeutics space going forward...
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised The post Merck gets on board with Moderna...